Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ Arthritis & Rheumati...arrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
Arthritis & Rheumatism
Article
Data sources: UnpayWall
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao
Arthritis & Rheumatism
Article . 2003 . Peer-reviewed
License: Wiley Online Library User Agreement
Data sources: Crossref
Arthritis & Rheumatism
Article . 2003
Data sources: Europe PubMed Central
https://dx.doi.org/10.1002/art...
Article
Data sources: Microsoft Academic Graph
 View all 2 versions
Claim

Endothelin and endothelin receptor antagonists in systemic rheumatic disease

descriptionPublicationkeyboard_double_arrow_right Article 01 May 2003 English Publisher:WileyJournal:Arthritis & Rheumatism, volume 48, pages 1,190-1,199 (issn: 0004-3591, eissn: 1529-0131, Copyright policy )
Authors: Maureen D, Mayes;

doi: 10.1002/art.10895

pmid: 12746891

Endothelin and endothelin receptor antagonists in systemic rheumatic disease

Keywords

CREST Syndrome, Endothelin Receptor Antagonists, Sulfonamides, Sequence Homology, Amino Acid, Receptors, Endothelin, Endothelins, Hypertension, Pulmonary, Bosentan, Humans, Controlled Clinical Trials as Topic, Connective Tissue Diseases, Antihypertensive Agents, Signal Transduction

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    		 121
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    		 Top 10%
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    		 Top 1%
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    		 Top 1%
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
121
Top 10%
Top 1%
Top 1%
bronze